Avadel Pharmaceuticals plc
US ˙ NasdaqGM ˙ US05337M1045
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityAVDL / Avadel Pharmaceuticals plc
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
D. E. Shaw & Co., Inc. ownership in AVDL / Avadel Pharmaceuticals plc

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 0 shares of Avadel Pharmaceuticals plc (US:AVDL) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 132,459 shares of Avadel Pharmaceuticals plc. The current value of the position is $0 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (AVDL) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AVDL / Avadel Pharmaceuticals plc Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AVADEL PHARMACEUTICALS COM SHS G29687103 0 -100.00 0
2026-02-17 2025-12-31 13F AVADEL PHARMACEUTICALS COM SHS G29687103 132,459 -237,170 -64.16 2,854 -49.43 0.0011
2025-11-14 2025-09-30 13F AVADEL PHARMACEUTICALS COM SHS G29687103 369,629 -67,926 -15.52 5,644 45.76 0.0032
2025-08-14 2025-06-30 13F AVADEL PHARMACEUTICALS COM SHS G29687103 437,555 -57,123 -11.55 3,872 -0.03 0.0027
2025-05-15 2025-03-31 13F AVADEL PHARMACEUTICALS COM SHS G29687103 494,678 185,020 59.75 3,873 19.02 0.0034
2025-02-14 2024-12-31 13F AVADEL PHARMACEUTICALS COM SHS G29687103 309,658 183,496 145.44 3,255 96.74 0.0024
2024-11-14 2024-09-30 13F AVADEL PHARMACEUTICALS COM SHS G29687103 126,162 91,290 261.79 1,655 237.55 0.0014
2024-08-14 2024-06-30 13F AVADEL PHARMACEUTICALS COM SHS G29687103 34,872 34,872 490 0.0005
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F AVADEL PHARMACEUTICALS COM SHS Call 0 -100.00 0 n/a n/a n/a
2026-02-17 2025-12-31 13F AVADEL PHARMACEUTICALS COM SHS Call 64,300 49.88 1,386 111.45 n/a n/a n/a
2025-11-14 2025-09-30 13F AVADEL PHARMACEUTICALS COM SHS Call 42,900 655 n/a n/a n/a
2025-05-15 2025-03-31 13F AVADEL PHARMACEUTICALS COM SHS Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F AVADEL PHARMACEUTICALS COM SHS Call 34,900 0.58 367 -19.56 n/a n/a n/a
2024-11-14 2024-09-30 13F AVADEL PHARMACEUTICALS COM SHS Call 34,700 15.67 455 8.08 n/a n/a n/a
2024-08-14 2024-06-30 13F AVADEL PHARMACEUTICALS COM SHS Call 30,000 422 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F AVADEL PHARMACEUTICALS COM SHS Put 0 -100.00 0 n/a n/a n/a
2026-02-17 2025-12-31 13F AVADEL PHARMACEUTICALS COM SHS Put 11,600 0.00 250 40.68 n/a n/a n/a
2025-11-14 2025-09-30 13F AVADEL PHARMACEUTICALS COM SHS Put 11,600 0.00 177 73.53 n/a n/a n/a
2025-08-14 2025-06-30 13F AVADEL PHARMACEUTICALS COM SHS Put 11,600 0.00 103 13.33 n/a n/a n/a
2025-05-15 2025-03-31 13F AVADEL PHARMACEUTICALS COM SHS Put 11,600 0.00 91 -25.62 n/a n/a n/a
2025-02-14 2024-12-31 13F AVADEL PHARMACEUTICALS COM SHS Put 11,600 122 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.